RxAll

RxAll, founded in 2016, addresses the global issue of substandard drugs causing around 1 million deaths annually. The healthcare-services startup offers RxDelivered, an online retailer of certified medications, and RxScanner, a patented drug authentication device. RxScanner employs a molecular sensor and cloud-based machine learning for non-destructive drug testing, boasting 99.9% accuracy. The app, available for Android and iOS, validates scans within 20 seconds, using a spectral signature database to identify counterfeit drugs. RxAll’s innovative solutions aim to combat the pervasive problem of counterfeit and substandard medications, enhancing drug safety globally.

• Address: New Haven, Connecticut, United States
• Email: info@rxall.net